2018-2025 Radiopharmaceuticals Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
SUMMARY
This report studies the Radiopharmaceuticals market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Radiopharmaceuticals market by product type and application/end industries.
The global Radiopharmaceuticals market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Radiopharmaceuticals.
United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.
Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Radiopharmaceuticals in these regions, from 2013 to 2025 (forecast), covering
This report studies the Radiopharmaceuticals market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Radiopharmaceuticals market by product type and application/end industries.
The global Radiopharmaceuticals market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Radiopharmaceuticals.
United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.
Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Radiopharmaceuticals in these regions, from 2013 to 2025 (forecast), covering
- United States
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
- Diagnostic Radioisotopes
- Therapeutic Radioisotopes
- Oncology
- Cardiology
- Other
2018-2025 RADIOPHARMACEUTICALS REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS
1 METHODOLOGY AND DATA SOURCE
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
2 RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Radiopharmaceuticals Product Overview
2.2 Radiopharmaceuticals Market Segment by Type
2.2.1 Diagnostic Radioisotopes
2.2.2 Therapeutic Radioisotopes
2.3 Global Radiopharmaceuticals Product Segment by Type
2.3.1 Global Radiopharmaceuticals Sales (K Doses) and Growth (%) by Type (2013, 2017 and 2025)
2.3.2 Global Radiopharmaceuticals Sales (K Doses) and Market Share (%) by Type (2013-2018)
2.3.3 Global Radiopharmaceuticals Revenue (Million USD) and Market Share (%) by Type (2013-2018)
2.3.4 Global Radiopharmaceuticals Price (USD/Dose) by Type (2013-2018)
2.4 United States Radiopharmaceuticals Product Segment by Type
2.4.1 United States Radiopharmaceuticals Sales (K Doses) and Growth by Type (2013, 2017 and 2025)
2.4.2 United States Radiopharmaceuticals Sales (K Doses) and Market Share by Type (2013-2018)
2.4.3 United States Radiopharmaceuticals Revenue (Million USD) and Market Share by Type (2013-2018)
2.4.4 United States Radiopharmaceuticals Price (USD/Dose) by Type (2013-2018)
3 RADIOPHARMACEUTICALS APPLICATION/END USERS
3.1 Radiopharmaceuticals Segment by Application/End Users
3.1.1 Oncology
3.1.2 Cardiology
3.1.3 Other
3.2 Global Radiopharmaceuticals Product Segment by Application
3.2.1 Global Radiopharmaceuticals Sales (K Doses) and CGAR (%) by Application (2013, 2017 and 2025)
3.2.2 Global Radiopharmaceuticals Sales (K Doses) and Market Share (%) by Application (2013-2018)
3.3 United States Radiopharmaceuticals Product Segment by Application
3.3.1 United States Radiopharmaceuticals Sales (K Doses) and CGAR (%) by Application (2013, 2017 and 2025)
3.3.2 United States Radiopharmaceuticals Sales (K Doses) and Market Share (%) by Application (2013-2018)
4 RADIOPHARMACEUTICALS MARKET STATUS AND OUTLOOK BY REGIONS
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Radiopharmaceuticals Market Size and CAGR by Regions (2013, 2017 and 2025)
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global Radiopharmaceuticals Sales and Revenue by Regions
4.2.1 Global Radiopharmaceuticals Sales (K Doses) and Market Share (%) by Regions (2013-2018)
4.2.2 Global Radiopharmaceuticals Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
4.2.3 Global Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
4.2.4 North America Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
4.2.5 Europe Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
4.2.6 Asia-Pacific Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
4.2.7 South America Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
4.2.8 Middle East and Africa Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
4.2.9 United States Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
5 GLOBAL RADIOPHARMACEUTICALS MARKET COMPETITION BY PLAYERS/MANUFACTURERS
5.1 Global Radiopharmaceuticals Sales (K Doses) and Market Share by Players (2013-2018)
5.2 Global Radiopharmaceuticals Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Radiopharmaceuticals Average Price (USD/Dose) by Players (2013-2018)
5.4 Global Top Players Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types
5.5 Radiopharmaceuticals Market Competitive Situation and Trends
5.5.1 Radiopharmaceuticals Market Concentration Rate
5.5.2 Global Radiopharmaceuticals Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion
6 UNITED STATES RADIOPHARMACEUTICALS MARKET COMPETITION BY PLAYERS/MANUFACTURERS
6.1 United States Radiopharmaceuticals Sales (K Doses) and Market Share by Players (2013-2018)
6.2 United States Radiopharmaceuticals Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Radiopharmaceuticals Average Price (USD/Dose) by Players (2013-2018)
6.4 United States Radiopharmaceuticals Market Share (%) of Top 3 and Top 5 Players
7 RADIOPHARMACEUTICALS PLAYERS/MANUFACTURERS PROFILES AND SALES DATA
7.1 Bracco Imaging
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Radiopharmaceuticals Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bracco Imaging Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.1.4 Main Business/Business Overview
7.2 Bayer
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Radiopharmaceuticals Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bayer Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.2.4 Main Business/Business Overview
7.3 Mallinckrodt
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Radiopharmaceuticals Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Mallinckrodt Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.3.4 Main Business/Business Overview
7.4 Nordion
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Radiopharmaceuticals Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Nordion Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.4.4 Main Business/Business Overview
7.5 Triad Isotopes
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Radiopharmaceuticals Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Triad Isotopes Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.5.4 Main Business/Business Overview
7.6 Lantheus
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Radiopharmaceuticals Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Lantheus Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.6.4 Main Business/Business Overview
7.7 IBA Group
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Radiopharmaceuticals Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 IBA Group Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.7.4 Main Business/Business Overview
7.8 GE Healthcare
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Radiopharmaceuticals Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 GE Healthcare Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.8.4 Main Business/Business Overview
7.9 China Isotope & Radiation
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Radiopharmaceuticals Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 China Isotope & Radiation Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.9.4 Main Business/Business Overview
7.10 Jubilant Pharma
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2 Radiopharmaceuticals Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Jubilant Pharma Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.10.4 Main Business/Business Overview
7.11 Eli Lilly
7.12 Advanced Accelerator Applications
7.13 SIEMENS
7.14 Dongcheng
7.15 Navidea
8 RADIOPHARMACEUTICALS MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS
8.1 Radiopharmaceuticals Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Radiopharmaceuticals Industrial Chain Analysis
8.4 Downstream Buyers in United States
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat
10 GLOBAL RADIOPHARMACEUTICALS MARKET FORECAST
10.1 Global Radiopharmaceuticals Sales, Revenue Forecast (2018-2025)
10.1.1 Global Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
10.1.1 Global Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Radiopharmaceuticals Market Forecast
10.2.1 United States Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
10.2.2 United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Radiopharmaceuticals Forecast by Regions
10.3.1 North America Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
10.3.2 Europe Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
10.3.3 Asia-Pacific Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
10.3.4 South America Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
10.3.5 Middle East and Africa Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
10.4 Radiopharmaceuticals Forecast by Type
10.4.1 Global Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast by Type (2018-2025)
10.4.2 United States Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Radiopharmaceuticals Forecast by Application
10.5.1 Global Radiopharmaceuticals Sales (K Doses) Forecast by Application (2018-2025)
10.5.2 United States Radiopharmaceuticals Sales (K Doses) Forecast by Application (2018-2025)
11 RESEARCH FINDINGS AND CONCLUSION
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 METHODOLOGY AND DATA SOURCE
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
2 RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Radiopharmaceuticals Product Overview
2.2 Radiopharmaceuticals Market Segment by Type
2.2.1 Diagnostic Radioisotopes
2.2.2 Therapeutic Radioisotopes
2.3 Global Radiopharmaceuticals Product Segment by Type
2.3.1 Global Radiopharmaceuticals Sales (K Doses) and Growth (%) by Type (2013, 2017 and 2025)
2.3.2 Global Radiopharmaceuticals Sales (K Doses) and Market Share (%) by Type (2013-2018)
2.3.3 Global Radiopharmaceuticals Revenue (Million USD) and Market Share (%) by Type (2013-2018)
2.3.4 Global Radiopharmaceuticals Price (USD/Dose) by Type (2013-2018)
2.4 United States Radiopharmaceuticals Product Segment by Type
2.4.1 United States Radiopharmaceuticals Sales (K Doses) and Growth by Type (2013, 2017 and 2025)
2.4.2 United States Radiopharmaceuticals Sales (K Doses) and Market Share by Type (2013-2018)
2.4.3 United States Radiopharmaceuticals Revenue (Million USD) and Market Share by Type (2013-2018)
2.4.4 United States Radiopharmaceuticals Price (USD/Dose) by Type (2013-2018)
3 RADIOPHARMACEUTICALS APPLICATION/END USERS
3.1 Radiopharmaceuticals Segment by Application/End Users
3.1.1 Oncology
3.1.2 Cardiology
3.1.3 Other
3.2 Global Radiopharmaceuticals Product Segment by Application
3.2.1 Global Radiopharmaceuticals Sales (K Doses) and CGAR (%) by Application (2013, 2017 and 2025)
3.2.2 Global Radiopharmaceuticals Sales (K Doses) and Market Share (%) by Application (2013-2018)
3.3 United States Radiopharmaceuticals Product Segment by Application
3.3.1 United States Radiopharmaceuticals Sales (K Doses) and CGAR (%) by Application (2013, 2017 and 2025)
3.3.2 United States Radiopharmaceuticals Sales (K Doses) and Market Share (%) by Application (2013-2018)
4 RADIOPHARMACEUTICALS MARKET STATUS AND OUTLOOK BY REGIONS
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Radiopharmaceuticals Market Size and CAGR by Regions (2013, 2017 and 2025)
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global Radiopharmaceuticals Sales and Revenue by Regions
4.2.1 Global Radiopharmaceuticals Sales (K Doses) and Market Share (%) by Regions (2013-2018)
4.2.2 Global Radiopharmaceuticals Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
4.2.3 Global Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
4.2.4 North America Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
4.2.5 Europe Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
4.2.6 Asia-Pacific Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
4.2.7 South America Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
4.2.8 Middle East and Africa Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
4.2.9 United States Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
5 GLOBAL RADIOPHARMACEUTICALS MARKET COMPETITION BY PLAYERS/MANUFACTURERS
5.1 Global Radiopharmaceuticals Sales (K Doses) and Market Share by Players (2013-2018)
5.2 Global Radiopharmaceuticals Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Radiopharmaceuticals Average Price (USD/Dose) by Players (2013-2018)
5.4 Global Top Players Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types
5.5 Radiopharmaceuticals Market Competitive Situation and Trends
5.5.1 Radiopharmaceuticals Market Concentration Rate
5.5.2 Global Radiopharmaceuticals Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion
6 UNITED STATES RADIOPHARMACEUTICALS MARKET COMPETITION BY PLAYERS/MANUFACTURERS
6.1 United States Radiopharmaceuticals Sales (K Doses) and Market Share by Players (2013-2018)
6.2 United States Radiopharmaceuticals Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Radiopharmaceuticals Average Price (USD/Dose) by Players (2013-2018)
6.4 United States Radiopharmaceuticals Market Share (%) of Top 3 and Top 5 Players
7 RADIOPHARMACEUTICALS PLAYERS/MANUFACTURERS PROFILES AND SALES DATA
7.1 Bracco Imaging
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Radiopharmaceuticals Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bracco Imaging Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.1.4 Main Business/Business Overview
7.2 Bayer
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Radiopharmaceuticals Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bayer Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.2.4 Main Business/Business Overview
7.3 Mallinckrodt
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Radiopharmaceuticals Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Mallinckrodt Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.3.4 Main Business/Business Overview
7.4 Nordion
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Radiopharmaceuticals Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Nordion Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.4.4 Main Business/Business Overview
7.5 Triad Isotopes
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Radiopharmaceuticals Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Triad Isotopes Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.5.4 Main Business/Business Overview
7.6 Lantheus
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Radiopharmaceuticals Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Lantheus Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.6.4 Main Business/Business Overview
7.7 IBA Group
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Radiopharmaceuticals Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 IBA Group Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.7.4 Main Business/Business Overview
7.8 GE Healthcare
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Radiopharmaceuticals Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 GE Healthcare Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.8.4 Main Business/Business Overview
7.9 China Isotope & Radiation
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Radiopharmaceuticals Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 China Isotope & Radiation Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.9.4 Main Business/Business Overview
7.10 Jubilant Pharma
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2 Radiopharmaceuticals Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Jubilant Pharma Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
7.10.4 Main Business/Business Overview
7.11 Eli Lilly
7.12 Advanced Accelerator Applications
7.13 SIEMENS
7.14 Dongcheng
7.15 Navidea
8 RADIOPHARMACEUTICALS MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS
8.1 Radiopharmaceuticals Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Radiopharmaceuticals Industrial Chain Analysis
8.4 Downstream Buyers in United States
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat
10 GLOBAL RADIOPHARMACEUTICALS MARKET FORECAST
10.1 Global Radiopharmaceuticals Sales, Revenue Forecast (2018-2025)
10.1.1 Global Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
10.1.1 Global Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Radiopharmaceuticals Market Forecast
10.2.1 United States Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
10.2.2 United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Radiopharmaceuticals Forecast by Regions
10.3.1 North America Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
10.3.2 Europe Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
10.3.3 Asia-Pacific Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
10.3.4 South America Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
10.3.5 Middle East and Africa Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
10.4 Radiopharmaceuticals Forecast by Type
10.4.1 Global Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast by Type (2018-2025)
10.4.2 United States Radiopharmaceuticals Sales (K Doses) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Radiopharmaceuticals Forecast by Application
10.5.1 Global Radiopharmaceuticals Sales (K Doses) Forecast by Application (2018-2025)
10.5.2 United States Radiopharmaceuticals Sales (K Doses) Forecast by Application (2018-2025)
11 RESEARCH FINDINGS AND CONCLUSION
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Radiopharmaceuticals Product Picture
Figure Global Radiopharmaceuticals Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Radiopharmaceuticals Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Diagnostic Radioisotopes
Table Major Players of Diagnostic Radioisotopes
Figure Global Diagnostic Radioisotopes Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Product Picture of Therapeutic Radioisotopes
Table Major Players of Therapeutic Radioisotopes
Figure Global Therapeutic Radioisotopes Sales (K Doses) and Growth Rate (%)(2013-2018)
Table Global Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Radiopharmaceuticals Sales (K Doses) by Type (2013-2018)
Table Global Radiopharmaceuticals Sales Share (%) by Type (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Type (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Type in 2017
Table Global Radiopharmaceuticals Revenue (Million USD) by Type (2013-2018)
Table Global Radiopharmaceuticals Revenue Share (%) by Type (2013-2018)
Figure Global Radiopharmaceuticals Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Radiopharmaceuticals Revenue Market Share (%) by Type
Table Global Radiopharmaceuticals Price (USD/Dose) by Type (2013-2018)
Table United States Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Radiopharmaceuticals Sales (K Doses) by Type (2013-2018)
Table United States Radiopharmaceuticals Sales Share (%) by Type (2013-2018)
Figure United States Radiopharmaceuticals Sales Market Share (%) by Type (2013-2018)
Figure United States Radiopharmaceuticals Sales Market Share (%) by Type in 2017
Table United States Radiopharmaceuticals Revenue (Million USD) by Type (2013-2018)
Table United States Radiopharmaceuticals Revenue Share (%) by Type (2013-2018)
Figure United States Radiopharmaceuticals Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Radiopharmaceuticals Revenue Market Share (%) by Type
Table United States Radiopharmaceuticals Price (USD/Dose) by Type (2013-2018)
Figure Oncology Examples
Figure Cardiology Examples
Figure Other Examples
Table Global Radiopharmaceuticals Sales (K Doses) Comparison by Application (2013-2025)
Table Global Radiopharmaceuticals Sales (K Doses) by Application (2013-2018)
Table Global Radiopharmaceuticals Sales Share (%) by Application (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Application (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Application in 2017
Table United States Radiopharmaceuticals Sales (K Doses) Comparison by Application (2013-2025)
Table United States Radiopharmaceuticals Sales (K Doses) by Application (2013-2018)
Table United States Radiopharmaceuticals Sales Share (%) by Application (2013-2018)
Figure United States Radiopharmaceuticals Sales Market Share (%) by Application (2013-2018)
Figure United States Radiopharmaceuticals Sales Market Share (%) by Application in 2017
Table Global Radiopharmaceuticals Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Radiopharmaceuticals Sales (K Doses) by Regions (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Regions (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Radiopharmaceuticals Sales Market Share (%) by Regions
Figure 2017 United States Radiopharmaceuticals Sales Market Share (%) in Global Market
Table Global Radiopharmaceuticals Revenue (Million USD) by Regions (2013-2018)
Table Global Radiopharmaceuticals Revenue Market Share (%) by Regions (2013-2018)
Figure Global Radiopharmaceuticals Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Radiopharmaceuticals Revenue Market Share (%) by Regions
Figure 2017 United States Radiopharmaceuticals Revenue Market Share (%) in Global Market
Table Global Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table North America Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Europe Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table South America Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table United States Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Global Radiopharmaceuticals Sales (K Doses) of Key Players (2013-2018)
Table Global Radiopharmaceuticals Sales Share (%) by Players (2013-2018)
Figure 2017 Global Radiopharmaceuticals Sales Share (%) by Players
Figure 2018 Global Radiopharmaceuticals Sales Share (%) by Players
Table Global Radiopharmaceuticals Revenue (Million USD) by Players (2013-2018)
Table Global Radiopharmaceuticals Revenue Share (%) by Players (2013-2018)
Table 2017 Global Radiopharmaceuticals Revenue Share (%) by Players
Table 2017 Global Radiopharmaceuticals Revenue Share (%) by Players
Table Global Market Radiopharmaceuticals Average Price (USD/Dose) by Players (2013-2018)
Table Global Radiopharmaceuticals Top Players Manufacturing Base Distribution and Sales Area
Table Global Radiopharmaceuticals Top Players Product Category
Figure Global Radiopharmaceuticals Market Share (%) of Top 3 Players
Figure Global Radiopharmaceuticals Market Share (%) of Top 5 Players
Table United States Radiopharmaceuticals Sales (K Doses) by Players (2013-2018)
Table United States Radiopharmaceuticals Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Radiopharmaceuticals Sales Share (%) by Players
Figure 2018 United States Radiopharmaceuticals Sales Share (%) by Players
Table United States Radiopharmaceuticals Revenue (Million USD) by Players (2013-2018)
Table United States Radiopharmaceuticals Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Radiopharmaceuticals Revenue Share (%) by Players
Table 2017 United States Radiopharmaceuticals Revenue Share (%) by Players
Table United States Market Radiopharmaceuticals Average Price (USD/Dose) by Players (2013-2018)
Figure United States Radiopharmaceuticals Market Share (%) of Top 3 Players
Figure United States Radiopharmaceuticals Market Share (%) of Top 5 Players
Table Bracco Imaging Basic Information List
Table Bracco Imaging Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Bracco Imaging Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Bracco Imaging Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Bracco Imaging Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Bayer Basic Information List
Table Bayer Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Bayer Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Bayer Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Bayer Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Mallinckrodt Basic Information List
Table Mallinckrodt Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Mallinckrodt Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Mallinckrodt Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Mallinckrodt Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Nordion Basic Information List
Table Nordion Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Nordion Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Nordion Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Nordion Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Triad Isotopes Basic Information List
Table Triad Isotopes Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Triad Isotopes Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Triad Isotopes Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Triad Isotopes Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Lantheus Basic Information List
Table Lantheus Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Lantheus Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Lantheus Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Lantheus Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table IBA Group Basic Information List
Table IBA Group Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure IBA Group Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure IBA Group Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure IBA Group Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table GE Healthcare Basic Information List
Table GE Healthcare Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure GE Healthcare Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure GE Healthcare Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure GE Healthcare Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table China Isotope & Radiation Basic Information List
Table China Isotope & Radiation Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure China Isotope & Radiation Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure China Isotope & Radiation Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure China Isotope & Radiation Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Jubilant Pharma Basic Information List
Table Jubilant Pharma Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Jubilant Pharma Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Jubilant Pharma Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Jubilant Pharma Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Eli Lilly Basic Information List
Table Advanced Accelerator Applications Basic Information List
Table SIEMENS Basic Information List
Table Dongcheng Basic Information List
Table Navidea Basic Information List
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radiopharmaceuticals
Figure Radiopharmaceuticals Industrial Chain Analysis
Table Major Buyers of Radiopharmaceuticals
Table Distributors/Traders List
Figure Global Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Global Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States RadiopharmaceuticalsRadiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Radiopharmaceuticals Sales (K Doses) Forecast by Regions (2018-2025)
Figure Global Radiopharmaceuticals Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure North America Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure South America Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Radiopharmaceuticals Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Radiopharmaceuticals Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Radiopharmaceuticals Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Radiopharmaceuticals Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Radiopharmaceuticals Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Radiopharmaceuticals Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Radiopharmaceuticals Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Radiopharmaceuticals Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Radiopharmaceuticals Sales (K Doses) Forecast by Application (2018-2025)
Figure Global Radiopharmaceuticals Sales Forecast by Application (2018-2025)
Table United States Radiopharmaceuticals Sales (K Doses) Forecast by Application (2018-2025)
Figure United States Radiopharmaceuticals Sales Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Radiopharmaceuticals Product Picture
Figure Global Radiopharmaceuticals Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Radiopharmaceuticals Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of Diagnostic Radioisotopes
Table Major Players of Diagnostic Radioisotopes
Figure Global Diagnostic Radioisotopes Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Product Picture of Therapeutic Radioisotopes
Table Major Players of Therapeutic Radioisotopes
Figure Global Therapeutic Radioisotopes Sales (K Doses) and Growth Rate (%)(2013-2018)
Table Global Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Radiopharmaceuticals Sales (K Doses) by Type (2013-2018)
Table Global Radiopharmaceuticals Sales Share (%) by Type (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Type (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Type in 2017
Table Global Radiopharmaceuticals Revenue (Million USD) by Type (2013-2018)
Table Global Radiopharmaceuticals Revenue Share (%) by Type (2013-2018)
Figure Global Radiopharmaceuticals Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Radiopharmaceuticals Revenue Market Share (%) by Type
Table Global Radiopharmaceuticals Price (USD/Dose) by Type (2013-2018)
Table United States Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Radiopharmaceuticals Sales (K Doses) by Type (2013-2018)
Table United States Radiopharmaceuticals Sales Share (%) by Type (2013-2018)
Figure United States Radiopharmaceuticals Sales Market Share (%) by Type (2013-2018)
Figure United States Radiopharmaceuticals Sales Market Share (%) by Type in 2017
Table United States Radiopharmaceuticals Revenue (Million USD) by Type (2013-2018)
Table United States Radiopharmaceuticals Revenue Share (%) by Type (2013-2018)
Figure United States Radiopharmaceuticals Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Radiopharmaceuticals Revenue Market Share (%) by Type
Table United States Radiopharmaceuticals Price (USD/Dose) by Type (2013-2018)
Figure Oncology Examples
Figure Cardiology Examples
Figure Other Examples
Table Global Radiopharmaceuticals Sales (K Doses) Comparison by Application (2013-2025)
Table Global Radiopharmaceuticals Sales (K Doses) by Application (2013-2018)
Table Global Radiopharmaceuticals Sales Share (%) by Application (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Application (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Application in 2017
Table United States Radiopharmaceuticals Sales (K Doses) Comparison by Application (2013-2025)
Table United States Radiopharmaceuticals Sales (K Doses) by Application (2013-2018)
Table United States Radiopharmaceuticals Sales Share (%) by Application (2013-2018)
Figure United States Radiopharmaceuticals Sales Market Share (%) by Application (2013-2018)
Figure United States Radiopharmaceuticals Sales Market Share (%) by Application in 2017
Table Global Radiopharmaceuticals Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Radiopharmaceuticals Sales (K Doses) by Regions (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Regions (2013-2018)
Figure Global Radiopharmaceuticals Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Radiopharmaceuticals Sales Market Share (%) by Regions
Figure 2017 United States Radiopharmaceuticals Sales Market Share (%) in Global Market
Table Global Radiopharmaceuticals Revenue (Million USD) by Regions (2013-2018)
Table Global Radiopharmaceuticals Revenue Market Share (%) by Regions (2013-2018)
Figure Global Radiopharmaceuticals Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Radiopharmaceuticals Revenue Market Share (%) by Regions
Figure 2017 United States Radiopharmaceuticals Revenue Market Share (%) in Global Market
Table Global Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table North America Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Europe Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table South America Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table United States Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Global Radiopharmaceuticals Sales (K Doses) of Key Players (2013-2018)
Table Global Radiopharmaceuticals Sales Share (%) by Players (2013-2018)
Figure 2017 Global Radiopharmaceuticals Sales Share (%) by Players
Figure 2018 Global Radiopharmaceuticals Sales Share (%) by Players
Table Global Radiopharmaceuticals Revenue (Million USD) by Players (2013-2018)
Table Global Radiopharmaceuticals Revenue Share (%) by Players (2013-2018)
Table 2017 Global Radiopharmaceuticals Revenue Share (%) by Players
Table 2017 Global Radiopharmaceuticals Revenue Share (%) by Players
Table Global Market Radiopharmaceuticals Average Price (USD/Dose) by Players (2013-2018)
Table Global Radiopharmaceuticals Top Players Manufacturing Base Distribution and Sales Area
Table Global Radiopharmaceuticals Top Players Product Category
Figure Global Radiopharmaceuticals Market Share (%) of Top 3 Players
Figure Global Radiopharmaceuticals Market Share (%) of Top 5 Players
Table United States Radiopharmaceuticals Sales (K Doses) by Players (2013-2018)
Table United States Radiopharmaceuticals Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Radiopharmaceuticals Sales Share (%) by Players
Figure 2018 United States Radiopharmaceuticals Sales Share (%) by Players
Table United States Radiopharmaceuticals Revenue (Million USD) by Players (2013-2018)
Table United States Radiopharmaceuticals Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Radiopharmaceuticals Revenue Share (%) by Players
Table 2017 United States Radiopharmaceuticals Revenue Share (%) by Players
Table United States Market Radiopharmaceuticals Average Price (USD/Dose) by Players (2013-2018)
Figure United States Radiopharmaceuticals Market Share (%) of Top 3 Players
Figure United States Radiopharmaceuticals Market Share (%) of Top 5 Players
Table Bracco Imaging Basic Information List
Table Bracco Imaging Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Bracco Imaging Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Bracco Imaging Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Bracco Imaging Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Bayer Basic Information List
Table Bayer Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Bayer Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Bayer Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Bayer Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Mallinckrodt Basic Information List
Table Mallinckrodt Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Mallinckrodt Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Mallinckrodt Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Mallinckrodt Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Nordion Basic Information List
Table Nordion Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Nordion Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Nordion Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Nordion Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Triad Isotopes Basic Information List
Table Triad Isotopes Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Triad Isotopes Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Triad Isotopes Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Triad Isotopes Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Lantheus Basic Information List
Table Lantheus Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Lantheus Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Lantheus Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Lantheus Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table IBA Group Basic Information List
Table IBA Group Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure IBA Group Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure IBA Group Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure IBA Group Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table GE Healthcare Basic Information List
Table GE Healthcare Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure GE Healthcare Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure GE Healthcare Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure GE Healthcare Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table China Isotope & Radiation Basic Information List
Table China Isotope & Radiation Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure China Isotope & Radiation Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure China Isotope & Radiation Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure China Isotope & Radiation Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Jubilant Pharma Basic Information List
Table Jubilant Pharma Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Jubilant Pharma Radiopharmaceuticals Sales Growth Rate (2013-2018)
Figure Jubilant Pharma Radiopharmaceuticals Sales Global Market Share (%)(2013-2018)
Figure Jubilant Pharma Radiopharmaceuticals Revenue Global Market Share (%)(2013-2018)
Table Eli Lilly Basic Information List
Table Advanced Accelerator Applications Basic Information List
Table SIEMENS Basic Information List
Table Dongcheng Basic Information List
Table Navidea Basic Information List
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radiopharmaceuticals
Figure Radiopharmaceuticals Industrial Chain Analysis
Table Major Buyers of Radiopharmaceuticals
Table Distributors/Traders List
Figure Global Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Global Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States RadiopharmaceuticalsRadiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Radiopharmaceuticals Sales (K Doses) Forecast by Regions (2018-2025)
Figure Global Radiopharmaceuticals Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure North America Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure South America Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Radiopharmaceuticals Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Radiopharmaceuticals Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Radiopharmaceuticals Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Radiopharmaceuticals Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Radiopharmaceuticals Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Radiopharmaceuticals Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Radiopharmaceuticals Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Radiopharmaceuticals Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Radiopharmaceuticals Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Radiopharmaceuticals Sales (K Doses) Forecast by Application (2018-2025)
Figure Global Radiopharmaceuticals Sales Forecast by Application (2018-2025)
Table United States Radiopharmaceuticals Sales (K Doses) Forecast by Application (2018-2025)
Figure United States Radiopharmaceuticals Sales Forecast by Application (2018-2025)
